ANRO vs GILD: Which Stock is Better?

Side-by-side comparison of Alto Neuroscience Inc and Gilead Sciences Inc in 2026

Comparison Updated:

ANRO

Alto Neuroscience Inc

$21.99

GILD

Gilead Sciences Inc

$143.93

Key Metrics Comparison

MetricANROGILDWinner
Market Cap$644.94M$178.68BGILD
P/E RatioN/A21.23GILD
EPS (TTM)$N/A$6.78GILD
Revenue Growth0.0%0.0%GILD
Gross Margin0.0%78.8%GILD

Analyze ANRO

Full quant analysis

Analyze GILD

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ANRO or GILD a better investment?

Comparing ANRO and GILD: Alto Neuroscience Inc has a market cap of $644.94M while Gilead Sciences Inc has $178.68B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ANRO and GILD?

ANRO (Alto Neuroscience Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ANRO or GILD?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: ANRO or GILD?

GILD has higher revenue growth at 0.0% vs 0.0% for ANRO.

Which company is more profitable: ANRO or GILD?

Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for ANRO.

Which is the larger company: ANRO or GILD?

Gilead Sciences Inc (GILD) is larger with a market cap of $178.68B compared to $644.94M for ANRO.

Should I buy ANRO or GILD in 2026?

Both ANRO and GILD have investment merit. ANRO trades at $21.99 while GILD trades at $143.93. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ANRO and GILD stock?

Key differences: Market Cap ($644.94M vs $178.68B), P/E Ratio (N/A vs 21.2x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).

Popular Stock Comparisons